Industry news 📰 Congratulations to Verona Pharma on the FDA approval of Ohtuvayre (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients. #copd #fdaapproval #lifesciencesnews #pharmanews #lifesciences
BREAKING NEWS: Today, the US FDA approved our drug for the maintenance treatment of #COPD in adults, making it the first inhaled product with a novel mechanism of action for this indication in over 20 years. Learn more: https://bit.ly/4bnUSxt #FDAApproval